L-oxiracetam oral instant membrane and preparation method thereof

An oral fast-dissolving film and oral film technology are applied in the field of oxiracetam, which can solve the problems of difficult control of disintegration time and tensile strength, restricting the development and application of oral film, and complex liposome preparation process. , to solve the mutual adhesion of film agents, improve bioavailability, and avoid elimination effects.

Active Publication Date: 2017-06-13
CHONGQING RUNZE PHARM CO LTD
View PDF11 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

This type of preparation is directly injected into tissues or blood vessels, and there is no absorption process or the absorption process is very short, so the blood concentration can quickly reach the peak to play a role; Most require higher equipment conditions, and the drugs in the injection are generally dispersed in water as micron-sized solid particles in the molecular state, with a large degree of dispersion, and high-temperature sterilization often results in drug hydrolysis, oxidation, and solid particle coalescence Stability issues such as large size
At the same time, because the injection directly and quickly enters the human body without the protection of the normal physiological barrier of the human body, if the dosage is improper or the injection is too fast, or there is a problem with the quality of the drug, it may bring harm to the patient, or even cause irreparable consequences.
In addition, injection pain, inability to administer drugs by the patient, local induration of injection, and vascular inflammation caused by intravenous injection are all problems in clinical application.
[0006] CN101732251A discloses a liposome of oxiracetam, which is prepared from oxiracetam, phospholipids, cholesterol, Tween 80 and an appropriate amount of osmotic pressure regulator and buffer solution; the liposome has good stability and encapsulation efficiency High, low toxicity and side effects; but the liposome preparation process is complicated, not suitable for large-scale production; more importantly, the curative effect of liposomes in the human body remains to be further studied, and there are few liposome preparations for clinical use in China at present
Although the oral film has many advantages, the limitations of its film-forming materials and preparation technology lead to low drug loading, the disintegration time and tensile strength are not easy to control, and most of the time it needs to mask the taste, which restricts the oral film. development and application of

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • L-oxiracetam oral instant membrane and preparation method thereof
  • L-oxiracetam oral instant membrane and preparation method thereof
  • L-oxiracetam oral instant membrane and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0073] 1) Dissolving 50 parts of maltodextrin in water to form a homogeneous viscous liquid, then adding 12 parts of triethyl citrate and mixing to form material I;

[0074] 2) Mix 8 parts of levoxiracetam, 29 parts of low-substituted hydroxypropyl cellulose and 1 part of aspartame, and disperse with water to form material II;

[0075] 3) Mix the material II with the material I, and stir at a speed of 500r / min to 600r / min for 60-100min to form levoxiracetam suspension viscous liquid without bubbles;

[0076] 4) Cast the levo-oxiracetam non-bubble suspension viscous liquid prepared in step 3) on a mold, dry at 90-100°C, cool at room temperature, form a film, and cut to obtain levo-oxiracetam oral instant dissolving film agent.

Embodiment 2

[0078] 1) Dissolving 55 parts of hydroxypropyl cellulose in water to form a homogeneous viscous liquid, then adding 15 parts of dibutyl phthalate and mixing to form material I;

[0079] 2) Mix 12 parts of levoxiracetam and 18 parts of pregelatinized starch, and disperse with water to form material II;

[0080] 3) Mix the material II with the material I, and stir at a speed of 500r / min to 900r / min for 50-80min to form levoxiracetam non-bubble suspension viscous liquid;

[0081] 4) Cast the levo-oxiracetam non-bubble suspension viscous liquid prepared in step 3) on a mold, dry at 85-100°C, cool at room temperature, form a film, and cut to obtain levo-oxiracetam oral instant dissolving film agent.

Embodiment 3

[0088] 1) Dissolve 60g of maltodextrin in water to form a homogeneous viscous liquid, then add 20g of triethyl citrate and mix well to form material I;

[0089] 2) Mix 15g of levoxiracetam and 30g of low-substituted hydroxypropyl cellulose, and disperse with water to form material II;

[0090] 3) Mix material II and material I, and stir at a speed of 500r / min to 600r / min for 80-100min to form levoxiracetam suspension viscous liquid without bubbles;

[0091] 4) Cast the levo-oxiracetam non-bubble suspension viscous liquid prepared in step 3) on a mold, dry at 90-100°C, cool at room temperature, form a film, and cut to obtain levo-oxiracetam oral instant dissolving film agent.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
thicknessaaaaaaaaaa
Login to view more

Abstract

The invention relates to an L-oxiracetam oral instant membrane, which is prepared from 3 to 20 parts of L-oxiracetam, 40 to 70 parts of membrane-forming material, 10 to 30 parts of filter, 5 to 20 parts of plasticizer and 2 to 4 parts of corrigent, wherein the membrane-forming material is maltodextrin. The L-oxiracetam oral instant membrane can be dissolved by a small amount of saliva in the oral cavity, and can be taken without water for delivery, so administration is convenient. After being stuck to the tongue, the L-oxiracetam oral instant membrane cannot be easily spit out, and therefore is suitable for children with dysphagia. Moreover, because the L-oxiracetam oral instant membrane can be absorbed through the mucous membrane, the first pass elimination effect is prevented, the bioavailability is increased, the dosage of medication is reduced, and thereby the side effect of the medicine is reduced. A preparation method of the invention is simple, the process cost is low, and therefore the preparation method is suitable for mass production.

Description

technical field [0001] The invention relates to an oxiracetam, in particular to a levo-oxiracetam oral instant film and a preparation method thereof. Background technique [0002] Oxiracetam, chemically named 4-hydroxy-2-oxo-1-pyrrolidineacetamide, is a nootropic drug synthesized for the first time in 1974 by the Italian Shi Kebichem company. Aminobutyric acid (GABOB) derivatives, can promote learning, enhance memory, and protect the central nervous system drugs of damaged nerve cells. Its structure is as follows: [0003] [0004] CN102552125A discloses that it can improve the memory and learning function of patients with mental retardation; it is also suitable for memory and mental retardation caused by mild to moderate vascular dementia, senile dementia and traumatic brain injury or as an auxiliary therapeutic drug. CN102600130A discloses its new clinical application for the treatment of epilepsy. At present, oxiracetam mainly includes injections, capsules and tablet...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/06A61K31/4015A61K47/36A61P25/28
Inventor 叶雷
Owner CHONGQING RUNZE PHARM CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products